News — Nuffield Department of Medicine

R21/Matrix-M malaria vaccine receives WHO recommendation for use

2 October 2023

The World Health Organization’s Strategic Advisory Group of Experts (SAGE) and Malaria Policy Advisory Group (MPAG) have recommended Oxford’s R21/Matrix-M™ malaria vaccine for use. The highly effective vaccine developed by the Jenner Institute and the Serum Institute of India has demonstrated high efficacy with a reassuring safety profile.

Beijing CDC Delegation Visits CAMS Oxford Institute

28 September 2023

A delegation from the Beijing Center for Disease Prevention and Control (Beijing CDC) visited the Chinese Academy of Medical Sciences Oxford Institute (COI) at NDM recently.

New vaccine trial for Middle East Respiratory Syndrome launched

18 September 2023

A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched on 15 September 2023. This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at the Pandemic Sciences Institute. It is the first trial in older people.

Monitoring the current Nipah virus outbreak in India

15 September 2023

Researchers at the Pandemic Sciences Institute (PSI) are closely monitoring the current outbreak of deadly Nipah virus in Kerala, India. To date, there have been five confirmed cases and two deaths reported, with many of those affected being family members of the first patient. The Institute has collaborations with scientists involved in the response, including virologists at the National Institute of Virology in Pune.

Clinical trial for Crimean-Congo haemorrhagic fever vaccine launched

11 September 2023

A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time. CCHF is on the World Health Organization's top priority watchlist for viruses that could cause a future pandemic, and yet no approved vaccines currently exist.

Six NDM researchers awarded Professorships

8 September 2023

We are delighted to announce that six researchers have been awarded the Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.

Impact of Ling’s legacy on CAMS Oxford Institute Researchers

1 September 2023

One year on from the launch of the Ling Felce Award for the training of researchers in Oxford, we reflect on the impact of the award and the generosity of our donors.

CEPI and Oxford to accelerate vaccine development against Disease X

30 August 2023

The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.

New collaboration to improve clinical research in low-resource settings

11 August 2023

Four major clinical trial networks, including Oxford University Clinical Research Unit, The Global Health Network, hosted by NDM’s Centre for Tropical Medicine and Global Health, based in low-resource settings are embarking on an exciting partnership with the Good Clinical Trials Collaborative (GCTC) to enhance clinical research in low-resource settings.

New collaboration to tackle antibiotic-resistant sepsis in African newborns

3 August 2023

The KEMRI-Wellcome Trust Research Programme from NDM has participated in a new European-African consortium to improve the way infections in newborns are treated. This project, called SNIP-AFRICA, aims to reduce mortality among neonates in hospitals with sepsis in Africa, in an era of increasing antimicrobial resistance.

New partnership to enhance global surveillance of pandemic threats

27 July 2023

PSI and the WHO Hub for Pandemic and Epidemic Intelligence will collaborate to improve the detection and tracking of infectious diseases.

R21 malaria vaccine cleared for use in Burkina Faso

24 July 2023

The R21/Matrix-M™ malaria vaccine, developed by the Jenner Institute, and manufactured by the Serum Institute of India which leverages Novavax’s adjuvant technology, has been licensed for use in Burkina Faso by the country’s regulatory agency, Agence Nationale de la Regulation Pharmaceutique.

Chinese Ministry of Education representatives visit CAMS Oxford Institute

30 June 2023

A delegation from the Ministry of Education (MoE) of the People's Republic of China visited the University of Oxford and was hosted at the Nuffield Department of Medicine (NDM) by Professor Tao Dong, Ita Askonas Professor of Translational Immunology and Director of the Chinese Academy of Medical Sciences Oxford Institute (COI).

Global collaboration accelerates research into visceral leishmaniasis

26 June 2023

NDM’s Infectious Diseases Data Observatory and its global collaborators have developed new case report forms providing researchers with a standardised means of recording any data on visceral leishmaniasis, allowing them to compare studies and relate data to the efficacy of visceral leishmaniasis treatments from different groups of researchers.

Assessing the drivers of recrudescent and persistent trachoma

21 June 2023

While 17 countries have now achieved trachoma elimination status, there is still work to be done, with trachoma responsible for the blindness or visual impairment of about 1.9 million people worldwide. Collaborators are being invited to join a new research project aimed at assessing the drivers for persistent and recrudescent trachoma.

CAMS-Oxford Institute Network Conference provides opportunity for international dialogue

20 June 2023

The annual conference of the Chinese Academy of Medical Sciences Oxford Institute took place in Chengdu, in the Sichuan province of China between 1-3 June 2023.

Prof Sir John Bell recognised in the King’s Birthday Honours

19 June 2023

Professor Sir John Irving Bell, Regius Professor of Medicine at the University of Oxford and former Head of Department of the Nuffield Department of Medicine, has been appointed a Companion of Honour in the King’s Birthday Honours list. He was knighted in 2015 for services to medicine, medical research and the life science industry.

Prof Chas Bountra appointed as NDM Head of Impact and Innovation

15 June 2023

In order to support the Nuffield Department of Medicine in seeking out new opportunities for innovation and delivering impact across its 24 units, Prof Richard Cornall, the Head of Department, has appointed Prof Bountra in a new role within NDM Strategic.

Investment is critical for protecting the UK from future pandemics

14 June 2023

Professor Sir Peter Horby, Director of NDM's Pandemic Sciences Institute, today advised a committee at the UK Houses of Parliament of the importance of strategic scientific research funding to prepare the UK for a future pandemic, alongside Professor Bryan Charleston, Director and CEO of The Pirbright Institute.

3.4 million assays run by NDM’s serology platform

7 June 2023

Within weeks of the pandemic starting, the Nuffield Department of Medicine (NDM) began antibody testing as part of the UK’s ONS COVID-19 Infection Survey. The platform successfully tested millions of blood samples over three years, providing invaluable information on how vaccinations and previous infections affect the chance of getting COVID-19 again.

Cookies on this website